Carisma Therapeutics Inc. (formerly CARMA Therapeutics) is a therapeutics company bringing the power of adoptive cellular immunotherapy to solid tumor patients through a differentiated platform using chimeric antigen receptor macrophages.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/27/18 | $53,000,000 | Series A |
AbbVie Biotech Ventures Agent Capital Grazia Equity HealthCap IP Group MRL Ventures Fund Penn Medicine TPG Biotech | undisclosed |
| 01/07/21 | $47,000,000 | Series B |
AbbVie Biotech Ventures Agent Capital HealthCap IP Group Livzon Pharmaceutical Group MRL Ventures Fund Solasta Ventures Symbiosis TPG Biotech | undisclosed |
| 03/02/21 | $12,000,000 | Series B |
4BIO Capital IP Group Penn Medicine | undisclosed |
